These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3048469

  • 1. Oral condition in children treated with bone marrow transplantation.
    Dahllöf G, Heimdahl A, Bolme P, Lönnqvist B, Ringdén O.
    Bone Marrow Transplant; 1988 Jan; 3(1):43-51. PubMed ID: 3048469
    [Abstract] [Full Text] [Related]

  • 2. Disturbances in the oral cavity in pediatric long-term survivors after different forms of antineoplastic therapy.
    Näsman M, Björk O, Söderhäll S, Ringdén O, Dahllöf G.
    Pediatr Dent; 1994 Jan; 16(3):217-23. PubMed ID: 8058547
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M, van Weel-Sipman MH, Zwinderman AH, Hoogerbrugge PM, Vossen JM, Egeler RM.
    Ned Tijdschr Geneeskd; 2002 Aug 17; 146(33):1542-6. PubMed ID: 12212502
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of bone marrow transplantation on dental status in children with leukaemia.
    Uderzo C, Fraschini D, Balduzzi A, Galimberti S, Arrigo C, Biagi E, Pignanelli M, Nicolini B, Rovelli A.
    Bone Marrow Transplant; 1997 Nov 17; 20(10):865-9. PubMed ID: 9404928
    [Abstract] [Full Text] [Related]

  • 7. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC.
    Bone Marrow Transplant; 1996 Jan 17; 17(1):13-8. PubMed ID: 8673048
    [Abstract] [Full Text] [Related]

  • 8. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, Carrà AM, Prete A, Montagna D, Comoli P, Taibi RM, Paolucci G.
    Bone Marrow Transplant; 1996 Jan 17; 17(1):31-7. PubMed ID: 8673051
    [Abstract] [Full Text] [Related]

  • 9. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation.
    Anderson PM, Ramsay NK, Shu XO, Rydholm N, Rogosheske J, Nicklow R, Weisdorf DJ, Skubitz KM.
    Bone Marrow Transplant; 1998 Aug 17; 22(4):339-44. PubMed ID: 9722068
    [Abstract] [Full Text] [Related]

  • 10. Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment.
    Nagler RM, Nagler A.
    Isr Med Assoc J; 2004 Mar 17; 6(3):167-72. PubMed ID: 15055275
    [Abstract] [Full Text] [Related]

  • 11. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
    Tichelli A, Duell T, Weiss M, Socié G, Ljungman P, Cohen A, van Lint M, Gratwohl A, Kolb HJ.
    Bone Marrow Transplant; 1996 Jun 17; 17(6):1105-11. PubMed ID: 8807122
    [Abstract] [Full Text] [Related]

  • 12. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 13. Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A.
    Locatelli F, Uderzo C, Dini G, Zecca M, Arcese W, Messina C, Andolina M, Miniero R, Porta F, Rovelli A.
    Bone Marrow Transplant; 1993 Dec 01; 12(6):627-33. PubMed ID: 8136746
    [Abstract] [Full Text] [Related]

  • 14. Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study.
    Dahllöf G, Bågesund M, Ringdén O.
    Bone Marrow Transplant; 1997 Sep 01; 20(6):479-83. PubMed ID: 9313881
    [Abstract] [Full Text] [Related]

  • 15. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease.
    Epstein JB, Reece DE.
    Bone Marrow Transplant; 1994 Jan 01; 13(1):81-6. PubMed ID: 8019458
    [Abstract] [Full Text] [Related]

  • 16. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S, Bishop MR, Tarantolo S, Cowles MK, Reed E, Anderson JR, Vose JM, Bierman P, Armitage JO, Kessinger A.
    Exp Hematol; 1995 Dec 01; 23(14):1503-8. PubMed ID: 8542938
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J, Ringdén O.
    Clin Transplant; 1994 Jun 01; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japan.
    Koga Y, Nagatoshi Y, Kawano Y, Okamura J.
    Bone Marrow Transplant; 2003 Jul 01; 32(2):171-6. PubMed ID: 12838282
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan 01; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 20. Oral recurrent human herpes virus infection and bone marrow transplantation survival.
    Gomez RS, Carneiro MA, Souza LN, Victória JM, de Azevedo WM, De Marco L, Kalapothakis E.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May 01; 91(5):552-6. PubMed ID: 11346734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.